Artiva Biotherapeutics, Inc. Common Stock (ARTV)

5.9

(11.11%)

Net Debt Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual net debt in 2023 was -36.59 Million USD , up 55.96% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly net debt in 2024 Q2 was -18.48 Million USD , up 42.14% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported annual net debt of -83.08 Million USD in 2022, up 47.81% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported annual net debt of -159.18 Million USD in 2021, down -582.42% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported quarterly net debt of -31.94 Million USD for 2024 Q1, up 12.71% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported quarterly net debt of -36.59 Million USD for 2023 FY, up 55.96% from previous quarter.

Annual Net Debt Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2019)

Historical Annual Net Debt of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -36.59 Million USD 55.96%
2022 -83.08 Million USD 47.81%
2021 -159.18 Million USD -582.42%
2020 -23.32 Million USD -518.4%
2019 -3.77 Million USD 0.0%

Peer Net Debt Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Net Debt Net Debt Difference